BeyondSpring (BYSI) Competitors $1.74 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends BYSI vs. MGTA, MEIP, FULC, ACRS, ATAI, LFCR, PSTX, LYEL, FATE, and ATYRShould you be buying BeyondSpring stock or one of its competitors? The main competitors of BeyondSpring include Magenta Therapeutics (MGTA), MEI Pharma (MEIP), Fulcrum Therapeutics (FULC), Aclaris Therapeutics (ACRS), Atai Life Sciences (ATAI), Lifecore Biomedical (LFCR), Poseida Therapeutics (PSTX), Lyell Immunopharma (LYEL), Fate Therapeutics (FATE), and Atyr PHARMA (ATYR). These companies are all part of the "medical" sector. BeyondSpring vs. Magenta Therapeutics MEI Pharma Fulcrum Therapeutics Aclaris Therapeutics Atai Life Sciences Lifecore Biomedical Poseida Therapeutics Lyell Immunopharma Fate Therapeutics Atyr PHARMA Magenta Therapeutics (NASDAQ:MGTA) and BeyondSpring (NASDAQ:BYSI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership, community ranking and earnings. Is MGTA or BYSI more profitable? BeyondSpring's return on equity of 0.00% beat Magenta Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Magenta TherapeuticsN/A -70.88% -57.27% BeyondSpring N/A N/A N/A Does the media refer more to MGTA or BYSI? In the previous week, Magenta Therapeutics' average media sentiment score of 0.95 beat BeyondSpring's score of 0.00 indicating that Magenta Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Magenta Therapeutics Positive BeyondSpring Neutral Which has better valuation & earnings, MGTA or BYSI? BeyondSpring has higher revenue and earnings than Magenta Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMagenta TherapeuticsN/AN/A-$76.46MN/AN/ABeyondSpring$1.88M36.20-$21.03MN/AN/A Do institutionals and insiders believe in MGTA or BYSI? 47.5% of Magenta Therapeutics shares are owned by institutional investors. Comparatively, 40.3% of BeyondSpring shares are owned by institutional investors. 15.2% of Magenta Therapeutics shares are owned by company insiders. Comparatively, 29.3% of BeyondSpring shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, MGTA or BYSI? Magenta Therapeutics has a beta of 2.12, indicating that its stock price is 112% more volatile than the S&P 500. Comparatively, BeyondSpring has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Does the MarketBeat Community favor MGTA or BYSI? BeyondSpring received 28 more outperform votes than Magenta Therapeutics when rated by MarketBeat users. Likewise, 66.79% of users gave BeyondSpring an outperform vote while only 57.09% of users gave Magenta Therapeutics an outperform vote. CompanyUnderperformOutperformMagenta TherapeuticsOutperform Votes15757.09% Underperform Votes11842.91% BeyondSpringOutperform Votes18566.79% Underperform Votes9233.21% SummaryBeyondSpring beats Magenta Therapeutics on 7 of the 10 factors compared between the two stocks. Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BYSI vs. The Competition Export to ExcelMetricBeyondSpringPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$67.91M$6.99B$5.38B$8.84BDividend YieldN/A8.15%5.13%4.09%P/E RatioN/A11.10105.1417.83Price / Sales36.20362.031,233.15158.41Price / CashN/A52.5940.4136.29Price / Book-1.9110.377.096.50Net Income-$21.03M$153.60M$119.65M$226.22M7 Day Performance7.41%4.60%2.25%4.03%1 Month Performance-21.62%-6.29%-2.33%4.92%1 Year Performance91.21%33.41%33.98%29.30% BeyondSpring Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BYSIBeyondSpringN/A$1.74flatN/A+91.2%$67.91M$1.88M0.0080MGTAMagenta TherapeuticsN/A$0.70-7.7%N/A+0.0%$42.44MN/A0.0067Gap DownMEIPMEI Pharma3.9289 of 5 stars$2.78-1.1%$7.00+151.8%-55.0%$18.52M$65.30M-0.40100Analyst ForecastFULCFulcrum Therapeutics3.5831 of 5 stars$3.25+9.4%$9.33+187.2%-28.6%$175.30M$80.87M-10.48100ACRSAclaris Therapeutics3.8433 of 5 stars$3.80-12.0%$8.80+131.6%+366.7%$271.44M$27.08M-7.3186Analyst UpgradeInsider TradeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeATAIAtai Life Sciences2.6057 of 5 stars$1.61+5.9%$9.00+459.0%+47.7%$270.16M$331,000.00-1.9983Analyst RevisionLFCRLifecore Biomedical3.5445 of 5 stars$7.31+4.7%$10.00+36.8%-1.9%$269.23M$128.26M91.38690Analyst ForecastNews CoverageGap UpPSTXPoseida Therapeutics3.9693 of 5 stars$2.73+0.7%$15.00+449.5%+4.6%$266.08M$150.86M-4.33260LYELLyell Immunopharma0.2949 of 5 stars$0.95+3.3%$1.00+5.3%-45.1%$265.26M$130,000.00-1.20270FATEFate Therapeutics3.9288 of 5 stars$2.29+10.6%$6.75+194.8%-4.2%$260.82M$13.45M-1.39550Analyst ForecastATYRAtyr PHARMA1.9949 of 5 stars$3.03+1.7%$19.25+535.3%N/A$254.34M$350,000.00-3.1856High Trading Volume Related Companies and Tools Related Companies MGTA Competitors MEIP Competitors FULC Competitors ACRS Competitors ATAI Competitors LFCR Competitors PSTX Competitors LYEL Competitors FATE Competitors ATYR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BYSI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BYSI Stock Alerts